Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 32

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 32
---
 member cash compensation. For information about the cash compensation policy for non-employee directors prior to May 2024, please see our definitive proxy statement for the fiscal year ended December 31, 2024 filed with the SEC on April 5, 2024.

22

TABLE OF CONTENTS

The board of directors approved the following retainer amounts in May 2024, effective July 2024.

| • | Annual cash retainer: $43,500 |

| • | Board of director non-executive chair: $32,500 |

| • | Audit committee chair: $20,000; |

| • | Audit committee member: $10,000; |

| • | Compensation committee chair: $15,000; |

| • | Compensation committee member: $7,500; |

| • | Nominating and corporate governance committee chair: $10,000; and |

| • | Nominating and corporate governance committee member: $5,000. |

Required Vote The Class I directors will be elected by a plurality of the voting power of the shares present virtually or represented by proxy at the Annual Meeting and entitled to vote on the election of directors. In other words, the two nominees receiving the highest number of “FOR” votes will be elected as Class I directors. You may vote (i) “FOR ALL NOMINEES” (ii) “WITHHOLD AUTHORITY FOR ALL NOMINEES” for each director nominee or (iii) “FOR ALL EXCEPT” one or more of the nominees you specify. Shares represented by executed proxies will be voted, if authority to do so is not expressly withheld, for the election of Natalie Holles and Garry Nicholson, “WITHHOLD” votes and broker non-votes will have no effect on the outcome of this proposal. OUR BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR ALL NOMINEES” IN THE ELECTION OF EACH OF THE TWO NOMINATED DIRECTORS.

23

TABLE OF CONTENTS

PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Our audit committee has selected PwC as our independent registered public accounting firm to perform the audit of our financial statements for the year ending December 31, 2025 and recommends that stockholders vote for ratification of such selection. The ratification of the selection of PwC as our independent registered public accounting firm for the year ending December 31, 2025 requires the affirmative vote